source
- Austria launches up to €100 million anchor investment for growth fund, aiming to channel half‑billion euros into biotechAustria's government announced a new national Startup & Scaleup Fund as part of the 2027/2028 budget, with an anchor investment of up to €100 million. The public money is designed to attract priva…
- Vaderis gets $152M to run Phase 3 of rare bleeding disorder treatmentVaderis Therapeutics’ bet that a type of treatment developed for cancers could work for a rare blood disorder is paying off. The 13-person Swiss startup raised $152 million in a Series B to run a ...Endpoints · 6m ago↗ source
- Tenax Therapeutics' heart failure drug TNX-103 misses primary endpoint in Phase 3, shares plunge 85%